We selected the basal forebrain as the brain area for drug injection in this study to observe whether basal forebrain BDNF signaling activation by ASO targeting ATXN2 mRNA could reverse the memory impairments induced by sleep deprivation. Here, ATXN2 is linked to memory impairment.